スフェロイドの市場規模、シェア、動向分析レポート：タイプ別、方法別、供給源別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

スフェロイド市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のスフェロイド市場規模は2030年までに24億6,000万米ドルに達し、2025年から2030年までのCAGRは22.7％で成長すると予測されています。

同市場は、従来の2次元培養よりも生理学的により適切な条件を提供する高度な3次元細胞培養モデルに対する需要の高まりにより、大きな牽引力となっています。スフェロイドは、細胞構造、栄養勾配、生体内組織の微小環境をよりよく模倣しており、薬剤スクリーニング、疾患モデリング、毒性試験、再生医療でますます使用されるようになっています。研究開発と製薬会社は、医薬品開発の成功率を向上させ、後期段階での失敗を減らすために、より正確な前臨床モデルを優先しているため、その応用範囲は、腫瘍学、神経学、代謝性疾患など、幅広い治療分野に及んでいます。

スフェロイドをハイスループットスクリーニング（HTS）システムに組み込むことで、製薬企業やバイオテクノロジー企業が大規模な化合物ライブラリーをより高い予測値で評価できるようになることも、大きな推進力となっています。また、スフェロイド作製を簡素化し、再現性を向上させる低粘着性プレート、ハンギングドロップシステム、マイクロ流体プラットフォームなどの新しいツールや技術の開発も市場を後押ししています。加えて、政府機関や民間投資家からの資金提供の増加が、学術的・商業的環境における3D培養研究の拡大を支えています。

COVID-19のパンデミックは、特にウイルス学と免疫学研究におけるスフェロイド・モデルの採用をさらに加速させました。研究者たちがヒト組織をより忠実に再現するモデルを求める中、スフェロイドはSARS-CoV-2感染メカニズム、宿主免疫応答、抗ウイルス薬の有効性を研究するのに有用であることが証明されました。パンデミックは、複雑な疾患を迅速に理解する上で、従来の2D培養や動物モデルの限界を浮き彫りにし、スフェロイドを含む3D培養技術への投資の増加につながりました。この変化はまた、研究室が将来の研究基盤を確保するために高度な培養システムを採用するようになり、長期的な市場の成長を支えました。

パンデミック後も、より倫理的で効率的な前臨床試験戦略への世界の後押しにより、スフェロイドをめぐる機運は続いています。規制機関や研究機関は、トランスレーショナルな成果を向上させながら動物実験を削減する上で、スフェロイドやその他の3Dモデルの価値をますます認識するようになっています。さらに、個別化医療の台頭と、疾患特異的なスフェロイドを形成するための患者由来細胞の使用は、カスタマイズされた医薬品開発と治療試験の新たな機会を開いています。これらの要因が相まって、スフェロイド市場は今後も堅調な見通しとなっています。

スフェロイド市場のレポートハイライト

• 多細胞腫瘍スフェロイド（MCTS）セグメントは、2024年に28.91%の最大の収益シェアを占め、予測期間中に最も速い成長率が見込まれます。MCTSはin vivoの腫瘍微小環境を忠実に再現し、より正確ながん研究や薬剤スクリーニングを可能にします。腫瘍の不均一性や薬剤耐性をモデル化する能力は、腫瘍学に特化した研究における採用を後押ししています。
• 吊り下げ滴下法セグメントは、2024年に31.34％の最大の収益シェアを占め、予測期間中に最も速い成長率が見込まれています。このシンプルで費用対効果の高い技術は、足場なしで均一なスフェロイド形成を容易にし、管理された実験セットアップに理想的です。その使いやすさとハイスループット・システムとの互換性が、研究の普及を支えています。
• 細胞株セグメントは、2024年に56.64%の大きな収益シェアを占めました。細胞株は、幅広い研究用途で3Dスフェロイドモデルを作製するための標準化された、再現可能でコスト効率の高いリソースを提供するため、主要な市場促進要因となっています。
• 再生医療分野は、予測期間中に最も高いCAGRを記録すると予想されています。スフェロイドは、細胞間の相互作用を促進し、本来の組織構造を模倣することによって、組織工学を強化します。機能的な組織構築物の開発におけるスフェロイドの役割は、再生治療において不可欠です。
• バイオテクノロジーと製薬産業セグメントは、2024年に46.33％の最大の収益シェアを占めました。これらの産業は、予測毒性学、有効性スクリーニング、疾患モデリングのためにスフェロイドを利用しています。ヒトに関連したスケーラブルな3Dモデルへの需要が、研究開発パイプラインへの統合を後押ししています。
• 北米は、規制の枠組みやヘルスケアのインフラが確立されているため、市場を独占しています。これらは、スフェロイドベースの製品の臨床応用と採用を促進し、市場成長をさらに後押ししています。
• Thermo Fisher Scientific Inc.、Corning Incorporated、Merck KGaA、Lonza、InSphero AG、Greiner Bio-One International GmbH、3D Biotek LLC、CN Bio Innovations、Kuraray Co.

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 スフェロイド市場の変数と動向

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• スフェロイド市場分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 タイプ別ビジネス分析

• セグメントダッシュボード
• 世界のスフェロイド市場：タイプ変動分析
• 世界のスフェロイド市場規模と動向分析（タイプ別、2018～2030年）
• 多細胞腫瘍スフェロイド（MCTS）
• ニューロスフェア
• マンモスフィア
• 肝球
• 胚様体

第5章 方法別ビジネス分析

• セグメントダッシュボード
• 世界のスフェロイド市場：手法変動分析
• 世界のスフェロイド市場規模と動向分析（方法別、2018～2030年）
• マイクロパターンプレート
• 低細胞接着プレート
• ハンギングドロップ法
• その他

第6章 供給源別ビジネス分析

• セグメントダッシュボード
• 世界のスフェロイド市場：供給源の変動分析
• 世界のスフェロイド市場規模と動向分析（供給源別、2018～2030年）
• 細胞株
• 一次細胞
• iPSC由来細胞

第7章 最終用途別ビジネス分析

• セグメントダッシュボード
• 世界のスフェロイド市場：最終用途変動分析
• 世界のスフェロイド市場規模と動向分析（最終用途別、2018～2030年）
• バイオテクノロジーおよび製薬産業
• 学術調査機関
• 病院と診断センター

第8章 用途別ビジネス分析

• セグメントダッシュボード
• 世界のスフェロイド市場：用途変動分析
• 世界のスフェロイド市場規模と動向分析（用途別、2018～2030年）
• 発生生物学
• パーソナライズ医療
• 再生医療
• 疾患病理学研究
• 薬物毒性および有効性試験

第9章 地域別ビジネス分析（国別、タイプ別、方法別、供給源別、用途別、最終用途別）

• セグメントダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
  • 北米市場推計・予測、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州市場推計・予測、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋市場推計・予測、2018年～2030年
  • 中国
  • 日本
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカ市場推計・予測、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • MEA市場推計・予測、2018年～2030年
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業分類
• 戦略マッピング
• 企業ポジション分析, 2024燃
• 企業プロファイル/リスト
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Lonza
  • CN Bio Innovations
  • 3D Biotek LLC
  • Kuraray Co., Ltd.
  • Tecan Group Ltd.
  • Corning Incorporated
  • Greiner Bio-One
  • InSphero

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America spheroids market, by type, 2018 - 2030 (USD Million)
• Table 3 North America spheroids market, by method, 2018 - 2030 (USD Million)
• Table 4 North America spheroids market, by source, 2018 - 2030 (USD Million)
• Table 5 North America spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 6 North America spheroids market, by application, 2018 - 2030 (USD Million)
• Table 7 North America spheroids market, by region, 2018 - 2030 (USD Million)
• Table 8 U.S. spheroids market, by type, 2018 - 2030 (USD Million)
• Table 9 U.S. spheroids market, by method, 2018 - 2030 (USD Million)
• Table 10 U.S. spheroids market, by source, 2018 - 2030 (USD Million)
• Table 11 U.S. spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 12 U.S. spheroids market, by application, 2018 - 2030 (USD Million)
• Table 13 Canada spheroids market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada spheroids market, by method, 2018 - 2030 (USD Million)
• Table 15 Canada spheroids market, by source, 2018 - 2030 (USD Million)
• Table 16 Canada spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Canada spheroids market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico spheroids market, by type, 2018 - 2030 (USD Million)
• Table 19 Mexico spheroids market, by method, 2018 - 2030 (USD Million)
• Table 20 Mexico spheroids market, by source, 2018 - 2030 (USD Million)
• Table 21 Mexico spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 22 Mexico spheroids market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe spheroids market, by type, 2018 - 2030 (USD Million)
• Table 24 Europe spheroids market, by method, 2018 - 2030 (USD Million)
• Table 25 Europe spheroids market, by source, 2018 - 2030 (USD Million)
• Table 26 Europe spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 27 Europe spheroids market, by application, 2018 - 2030 (USD Million)
• Table 28 Europe spheroids market, by region, 2018 - 2030 (USD Million)
• Table 29 Germany spheroids market, by type, 2018 - 2030 (USD Million)
• Table 30 Germany spheroids market, by method, 2018 - 2030 (USD Million)
• Table 31 Germany spheroids market, by source, 2018 - 2030 (USD Million)
• Table 32 Germany spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 33 Germany spheroids market, by application, 2018 - 2030 (USD Million)
• Table 34 UK spheroids market, by type, 2018 - 2030 (USD Million)
• Table 35 UK spheroids market, by method, 2018 - 2030 (USD Million)
• Table 36 UK spheroids market, by source, 2018 - 2030 (USD Million)
• Table 37 UK spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 38 UK spheroids market, by application, 2018 - 2030 (USD Million)
• Table 39 France spheroids market, by type, 2018 - 2030 (USD Million)
• Table 40 France spheroids market, by method, 2018 - 2030 (USD Million)
• Table 41 France spheroids market, by source, 2018 - 2030 (USD Million)
• Table 42 France spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 43 France spheroids market, by application, 2018 - 2030 (USD Million)
• Table 44 Italy spheroids market, by type, 2018 - 2030 (USD Million)
• Table 45 Italy spheroids market, by method, 2018 - 2030 (USD Million)
• Table 46 Italy spheroids market, by source, 2018 - 2030 (USD Million)
• Table 47 Italy spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 48 Italy spheroids market, by application, 2018 - 2030 (USD Million)
• Table 49 Spain spheroids market, by type, 2018 - 2030 (USD Million)
• Table 50 Spain spheroids market, by method, 2018 - 2030 (USD Million)
• Table 51 Spain spheroids market, by source, 2018 - 2030 (USD Million)
• Table 52 Spain spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 53 Spain spheroids market, by application, 2018 - 2030 (USD Million)
• Table 54 Sweden spheroids market, by type, 2018 - 2030 (USD Million)
• Table 55 Sweden spheroids market, by method, 2018 - 2030 (USD Million)
• Table 56 Sweden spheroids market, by source, 2018 - 2030 (USD Million)
• Table 57 Sweden spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 58 Sweden spheroids market, by application, 2018 - 2030 (USD Million)
• Table 59 Norway spheroids market, by type, 2018 - 2030 (USD Million)
• Table 60 Norway spheroids market, by method, 2018 - 2030 (USD Million)
• Table 61 Norway spheroids market, by source, 2018 - 2030 (USD Million)
• Table 62 Norway spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 63 Norway spheroids market, by application, 2018 - 2030 (USD Million)
• Table 64 Denmark spheroids market, by type, 2018 - 2030 (USD Million)
• Table 65 Denmark spheroids market, by method, 2018 - 2030 (USD Million)
• Table 66 Denmark spheroids market, by source, 2018 - 2030 (USD Million)
• Table 67 Denmark spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 68 Denmark spheroids market, by application, 2018 - 2030 (USD Million)
• Table 69 APAC spheroids market, by type, 2018 - 2030 (USD Million)
• Table 70 APAC spheroids market, by method, 2018 - 2030 (USD Million)
• Table 71 APAC spheroids market, by source, 2018 - 2030 (USD Million)
• Table 72 APAC spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 73 APAC spheroids market, by application, 2018 - 2030 (USD Million)
• Table 74 APAC spheroids market, by region, 2018 - 2030 (USD Million)
• Table 75 China spheroids market, by type, 2018 - 2030 (USD Million)
• Table 76 China spheroids market, by method, 2018 - 2030 (USD Million)
• Table 77 China spheroids market, by source, 2018 - 2030 (USD Million)
• Table 78 China spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 79 China spheroids market, by application, 2018 - 2030 (USD Million)
• Table 80 Japan spheroids market, by type, 2018 - 2030 (USD Million)
• Table 81 Japan spheroids market, by method, 2018 - 2030 (USD Million)
• Table 82 Japan spheroids market, by source, 2018 - 2030 (USD Million)
• Table 83 Japan spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 84 Japan spheroids market, by application, 2018 - 2030 (USD Million)
• Table 85 India spheroids market, by type, 2018 - 2030 (USD Million)
• Table 86 India spheroids market, by method, 2018 - 2030 (USD Million)
• Table 87 India spheroids market, by source, 2018 - 2030 (USD Million)
• Table 88 India spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 89 India spheroids market, by application, 2018 - 2030 (USD Million)
• Table 90 Thailand spheroids market, by type, 2018 - 2030 (USD Million)
• Table 91 Thailand spheroids market, by method, 2018 - 2030 (USD Million)
• Table 92 Thailand spheroids market, by source, 2018 - 2030 (USD Million)
• Table 93 Thailand spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 94 Thailand spheroids market, by application, 2018 - 2030 (USD Million)
• Table 95 South Korea spheroids market, by type, 2018 - 2030 (USD Million)
• Table 96 South Korea spheroids market, by method, 2018 - 2030 (USD Million)
• Table 97 South Korea spheroids market, by source, 2018 - 2030 (USD Million)
• Table 98 South Korea spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 99 South Korea spheroids market, by application, 2018 - 2030 (USD Million)
• Table 100 Australia spheroids market, by type, 2018 - 2030 (USD Million)
• Table 101 Australia spheroids market, by method, 2018 - 2030 (USD Million)
• Table 102 Australia spheroids market, by source, 2018 - 2030 (USD Million)
• Table 103 Australia spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 104 Australia spheroids market, by application, 2018 - 2030 (USD Million)
• Table 105 Latin America spheroids market, by type, 2018 - 2030 (USD Million)
• Table 106 Latin America spheroids market, by method, 2018 - 2030 (USD Million)
• Table 107 Latin America spheroids market, by source, 2018 - 2030 (USD Million)
• Table 108 Latin America spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 109 Latin America spheroids market, by application, 2018 - 2030 (USD Million)
• Table 110 Latin America spheroids market, by region, 2018 - 2030 (USD Million)
• Table 111 Brazil spheroids market, by type, 2018 - 2030 (USD Million)
• Table 112 Brazil spheroids market, by method, 2018 - 2030 (USD Million)
• Table 113 Brazil spheroids market, by source, 2018 - 2030 (USD Million)
• Table 114 Brazil spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 115 Brazil spheroids market, by application, 2018 - 2030 (USD Million)
• Table 116 Argentina spheroids market, by type, 2018 - 2030 (USD Million)
• Table 117 Argentina spheroids market, by method, 2018 - 2030 (USD Million)
• Table 118 Argentina spheroids market, by source, 2018 - 2030 (USD Million)
• Table 119 Argentina spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 120 Argentina spheroids market, by application, 2018 - 2030 (USD Million)
• Table 121 Middle East and Africa spheroids market, by type, 2018 - 2030 (USD Million)
• Table 122 Middle East and Africa spheroids market, by method, 2018 - 2030 (USD Million)
• Table 123 Middle East and Africa spheroids market, by source, 2018 - 2030 (USD Million)
• Table 124 Middle East and Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 125 Middle East and Africa spheroids market, by application, 2018 - 2030 (USD Million)
• Table 126 Middle East and Africa spheroids market, by region, 2018 - 2030 (USD Million)
• Table 127 South Africa spheroids market, by type, 2018 - 2030 (USD Million)
• Table 128 South Africa spheroids market, by method, 2018 - 2030 (USD Million)
• Table 129 South Africa spheroids market, by source, 2018 - 2030 (USD Million)
• Table 130 South Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 131 South Africa spheroids market, by application, 2018 - 2030 (USD Million)
• Table 132 Saudi Arabia spheroids market, by type, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia spheroids market, by method, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia spheroids market, by source, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia spheroids market, by application, 2018 - 2030 (USD Million)
• Table 137 UAE spheroids market, by type, 2018 - 2030 (USD Million)
• Table 138 UAE spheroids market, by method, 2018 - 2030 (USD Million)
• Table 139 UAE spheroids market, by source, 2018 - 2030 (USD Million)
• Table 140 UAE spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 141 UAE spheroids market, by application, 2018 - 2030 (USD Million)
• Table 142 Kuwait spheroids market, by type, 2018 - 2030 (USD Million)
• Table 143 Kuwait spheroids market, by method, 2018 - 2030 (USD Million)
• Table 144 Kuwait spheroids market, by source, 2018 - 2030 (USD Million)
• Table 145 Kuwait spheroids market, by End Use, 2018 - 2030 (USD Million)
• Table 146 Kuwait spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Spheroids: market outlook
• Fig. 9 Spheroids competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Spheroids market driver impact
• Fig. 13 Spheroids market restraint impact
• Fig. 14 Spheroids market strategic initiatives analysis
• Fig. 15 Spheroids market: type movement analysis
• Fig. 16 Spheroids market: type outlook and key takeaways
• Fig. 17 MCTS market estimates and forecast, 2018 - 2030
• Fig. 18 Neurospheres market estimates and forecast, 2018 - 2030
• Fig. 19 Mammospheres market estimates and forecast, 2018 - 2030
• Fig. 20 Hepatospheres market estimates and forecast, 2018 - 2030
• Fig. 21 Embryoid bodies market estimates and forecast, 2018 - 2030
• Fig. 22 Spheroids market: method movement analysis
• Fig. 23 Spheroids market: method outlook and key takeaways
• Fig. 24 Micropatterned plates market estimates and forecast, 2018 - 2030
• Fig. 25 Low cell attachment plates market estimates and forecast, 2018 - 2030
• Fig. 26 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
• Fig. 27 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
• Fig. 28 Spheroids market: source movement analysis
• Fig. 29 Spheroids market: source outlook and key takeaways
• Fig. 30 Cell line market estimates and forecast, 2018 - 2030
• Fig. 31 Primary cell market estimates and forecast, 2018 - 2030
• Fig. 32 iPSCs derived cells market estimates and forecast, 2018 - 2030
• Fig. 33 Spheroids market: End Use movement analysis
• Fig. 34 Spheroids market: End Use outlook and key takeaways
• Fig. 35 Biotechnology and pharmaceutical industries market estimates and forecast, 2018- 2030
• Fig. 36 Academic & research institutes market estimates and forecast, 2018 - 2030
• Fig. 37 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
• Fig. 38 Spheroids market: application movement analysis
• Fig. 39 Spheroids market: application outlook and key takeaways
• Fig. 40 Developmental biology market estimates and forecast, 2018 - 2030
• Fig. 41 Personalized medicine market estimates and forecast, 2018 - 2030
• Fig. 42 Regenerative medicine market estimates and forecast, 2018 - 2030
• Fig. 43 Disease pathology studies market estimates and forecast, 2018 - 2030
• Fig. 44 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
• Fig. 45 Global Spheroids market: regional movement analysis
• Fig. 46 Global Spheroids market: regional outlook and key takeaways
• Fig. 47 North America
• Fig. 48 North America market estimates and forecast, 2018 - 2030
• Fig. 49 U.S. key country dynamics
• Fig. 50 U.S. market estimates and forecast, 2018 - 2030
• Fig. 51 Canada key country dynamics
• Fig. 52 Canada market estimates and forecast, 2018 - 2030
• Fig. 53 Mexico key country dynamics
• Fig. 54 Mexico market estimates and forecast, 2018 - 2030
• Fig. 55 Europe
• Fig. 56 Europe. market estimates and forecast, 2018 - 2030
• Fig. 57 UK key country dynamics
• Fig. 58 UK market estimates and forecast, 2018 - 2030
• Fig. 59 Germany key country dynamics
• Fig. 60 Germany market estimates and forecast, 2018 - 2030
• Fig. 61 France key country dynamics
• Fig. 62 France market estimates and forecast, 2018 - 2030
• Fig. 63 Italy key country dynamics
• Fig. 64 Italy market estimates and forecast, 2018 - 2030
• Fig. 65 Spain key country dynamics
• Fig. 66 Spain market estimates and forecast, 2018 - 2030
• Fig. 67 Sweden key country dynamics
• Fig. 68 Sweden market estimates and forecast, 2018 - 2030
• Fig. 69 Norway key country dynamics
• Fig. 70 Norway market estimates and forecast, 2018 - 2030
• Fig. 71 Denmark key country dynamics
• Fig. 72 Denmark market estimates and forecast, 2018 - 2030
• Fig. 73 Asia Pacific
• Fig. 74 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 75 China key country dynamics
• Fig. 76 China market estimates and forecast, 2018 - 2030
• Fig. 77 Japan key country dynamics
• Fig. 78 Japan market estimates and forecast, 2018 - 2030
• Fig. 79 India key country dynamics
• Fig. 80 India market estimates and forecast, 2018 - 2030
• Fig. 81 Australia key country dynamics
• Fig. 82 Australia market estimates and forecast, 2018 - 2030
• Fig. 83 Thailand key country dynamics
• Fig. 84 Thailand market estimates and forecast, 2018 - 2030
• Fig. 85 South Korea key country dynamics
• Fig. 86 South Korea market estimates and forecast, 2018 - 2030
• Fig. 87 Latin America
• Fig. 88 Latin America market estimates and forecast, 2018 - 2030
• Fig. 89 Brazil key country dynamics
• Fig. 90 Brazil market estimates and forecast, 2018 - 2030
• Fig. 91 Argentina key country dynamics
• Fig. 92 Argentina market estimates and forecast, 2018 - 2030
• Fig. 93 Middle East and Africa
• Fig. 94 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 95 Saudi Arabia key country dynamics
• Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 97 South Africa key country dynamics
• Fig. 98 South Africa market estimates and forecast, 2018 - 2030
• Fig. 99 UAE key country dynamics
• Fig. 100 UAE market estimates and forecast, 2018 - 2030
• Fig. 101 Kuwait key country dynamics
• Fig. 102 Kuwait market estimates and forecast, 2018 - 2030

Spheroids Market Growth & Trends:

The global spheroids market size is expected to reach USD 2.46 billion by 2030 and is anticipated to grow at a CAGR of 22.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has gained significant traction due to the growing demand for advanced 3D cell culture models that offer more physiologically relevant conditions than traditional 2D cultures. Spheroids, which better mimic the cellular architecture, nutrient gradients, and microenvironment of tissues in vivo, are increasingly used in drug screening, disease modeling, toxicology testing, and regenerative medicine. Their application spans a wide range of therapeutic areas, including oncology, neurology, and metabolic diseases, as researchers and pharmaceutical companies prioritize more accurate preclinical models to improve drug development success rates and reduce late-stage failures.

Another major driver is the integration of spheroids into high-throughput screening (HTS) systems, enabling pharmaceutical and biotechnology companies to evaluate large compound libraries with greater predictive value. The market is also fueled by developing novel tools and technologies such as low-attachment plates, hanging drop systems, and microfluidic platforms that simplify spheroid generation and improve reproducibility. In addition, increased funding from government agencies and private investors has supported the expansion of 3D culture research in academic and commercial settings.

The COVID-19 pandemic further accelerated the adoption of spheroid models, particularly in virology and immunology research. As researchers sought models that more closely represented human tissues, spheroids proved valuable for studying SARS-CoV-2 infection mechanisms, host immune responses, and antiviral drug efficacy. The pandemic highlighted the limitations of conventional 2D cultures and animal models in rapidly understanding complex diseases, leading to increased investment in 3D culture technologies, including spheroids. This shift also supported long-term market growth as laboratories increasingly adopted advanced culture systems to future-proof research infrastructure.

Post-pandemic, the momentum around spheroids has continued, driven by a global push toward more ethical and efficient preclinical testing strategies. Regulatory agencies and research institutions increasingly recognize the value of spheroids and other 3D models in reducing animal testing while improving translational outcomes. Furthermore, the rise of personalized medicine and the use of patient-derived cells to form disease-specific spheroids are opening new opportunities for customized drug development and therapeutic testing. Together, these factors are shaping a robust outlook for the market in the years ahead.

Spheroids Market Report Highlights:

• The multicellular tumor spheroids (MCTS) segment accounted for the largest revenue share of 28.91% in 2024 and is expected to have the fastest growth rate over the forecast period. MCTS closely replicates the in vivo tumor microenvironment, enabling more accurate cancer research and drug screening. Their ability to model tumor heterogeneity and drug resistance drives their adoption in oncology-focused studies.
• The hanging drop method segment accounted for the largest revenue share of 31.34% in 2024 and is expected to have the fastest growth rate over the forecast period. This simple and cost-effective technique facilitates uniform spheroid formation without scaffolds, ideal for controlled experimental setups. Its ease of use and compatibility with high-throughput systems support widespread research adoption.
• The cell line segment accounted for a larger revenue share of 56.64% in 2024. Cell lines are a major market driver because they provide a standardized, reproducible, and cost-effective resource for generating 3D spheroid models across a wide range of research applications.
• The regenerative medicine segment is expected to witness the highest CAGR over the forecast period. Spheroids enhance tissue engineering by promoting cell-cell interactions and mimicking native tissue structures. Their role in developing functional tissue constructs makes them essential in regenerative therapies.
• The biotechnology and pharmaceutical industries segment accounted for the largest revenue share of 46.33% in 2024. These industries utilize spheroids for predictive toxicology, efficacy screening, and disease modeling. The demand for human-relevant, scalable 3D models drives their integration into R&D pipelines.
• North America dominated the market due to its well-established regulatory frameworks and healthcare infrastructure. These facilitate the clinical translation and adoption of spheroid-based products, further propelling market growth.
• Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Lonza, InSphero AG, Greiner Bio-One International GmbH, 3D Biotek LLC, CN Bio Innovations, Kuraray Co., Ltd., and Tecan Group Ltd. are some of the market players operating in the market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Method
  • 1.1.3. Source
  • 1.1.4. Application
  • 1.1.5. End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Spheroids Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High adoption of spheroids in drug discovery
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Challenges associated with 3D cell culturing
    • 3.2.2.2. Ethical issues associated with spheroid cultures
• 3.3. Spheroids Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Spheroids Market: Type Movement Analysis
• 4.3. Global Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Multicellular tumor spheroids (MCTS)
  • 4.4.1. MCTS market estimates and forecast, 2018 - 2030
• 4.5. Neurospheres
  • 4.5.1. Neurospheres market estimates and forecast, 2018 - 2030
• 4.6. Mammospheres
  • 4.6.1. Mammospheres market estimates and forecast, 2018 - 2030
• 4.7. Hepatospheres
  • 4.7.1. Hepatospheres market estimates and forecast, 2018 - 2030
• 4.8. Embryoid bodies
  • 4.8.1. Embryoid bodies market estimates and forecast, 2018 - 2030

Chapter 5. Method Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Spheroids Market: Method Movement Analysis
• 5.3. Global Spheroids Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
• 5.4. Micropatterned Plates
  • 5.4.1. Micropatterned plates market estimates and forecast, 2018 - 2030
• 5.5. Low Cell Attachment Plates
  • 5.5.1. Low cell attachment plates market estimates and forecast, 2018 - 2030
• 5.6. Hanging Drop Method
  • 5.6.1. Hanging drop method market estimates and forecast, 2018 - 2030
• 5.7. Others
  • 5.7.1. Other methods market estimates and forecast, 2018 - 2030

Chapter 6. Source Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Spheroids Market: Source Movement Analysis
• 6.3. Global Spheroids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
• 6.4. Cell Line
  • 6.4.1. Cell line market estimates and forecast, 2018 - 2030
• 6.5. Primary Cell
  • 6.5.1. Primary cell market estimates and forecast, 2018 - 2030
• 6.6. iPSCs Derived Cells
  • 6.6.1. iPSCs derived cells market estimates and forecast, 2018 - 2030

Chapter 7. End Use Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Spheroids Market: End Use Movement Analysis
• 7.3. Global Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Biotechnology and Pharmaceutical Industries
  • 7.4.1. Biotechnology and pharmaceutical industries market estimates and forecast 2018 to 2030, (USD million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & research institutes market estimates and forecast 2018 to 2030, (USD Million)
• 7.6. Hospitals and Diagnostic Centers
  • 7.6.1. Hospitals and diagnostic centers market estimates and forecast 2018 to 2030, (USD million)

Chapter 8. Application Business Analysis

• 8.1. Segment Dashboard
• 8.2. Global Spheroids Market: Application Movement Analysis
• 8.3. Global Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 8.4. Developmental Biology
  • 8.4.1. Developmental biology market estimates and forecast 2018 to 2030, (USD million)
• 8.5. Personalized Medicine
  • 8.5.1. Personalized medicine market estimates and forecast 2018 to 2030, (USD Million)
• 8.6. Regenerative Medicine
  • 8.6.1. Regenerative medicine market estimates and forecast 2018 to 2030, (USD million)
• 8.7. Disease Pathology Studies
  • 8.7.1. Disease pathology studies market estimates and forecast 2018 to 2030, (USD Million)
• 8.8. Drug Toxicity & Efficacy Testing
  • 8.8.1. Drug toxicity & efficacy testing market estimates and forecast 2018 to 2030, (USD Million)

Chapter 9. Regional Business Analysis, by Country, Type, Method, Source, Application, & End Use

• 9.1. Segment Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Target Disease Prevalence
    • 9.3.2.3. Competitive Scenario
    • 9.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Target Disease Prevalence
    • 9.3.3.3. Competitive Scenario
    • 9.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Target Disease Prevalence
    • 9.3.4.3. Competitive Scenario
    • 9.3.4.4. Mexico Market estimates and forecast, 2018 - 2030 (USD Billion)
• 9.4. Europe
  • 9.4.1. Europe Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Target Disease Prevalence
    • 9.4.2.3. Competitive Scenario
    • 9.4.2.4. UK Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Target Disease Prevalence
    • 9.4.3.3. Competitive Scenario
    • 9.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Target Disease Prevalence
    • 9.4.4.3. Competitive Scenario
    • 9.4.4.4. France Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Target Disease Prevalence
    • 9.4.5.3. Competitive Scenario
    • 9.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Target Disease Prevalence
    • 9.4.6.3. Competitive Scenario
    • 9.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Target Disease Prevalence
    • 9.4.7.3. Competitive Scenario
    • 9.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Target Disease Prevalence
    • 9.4.8.3. Competitive Scenario
    • 9.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Target Disease Prevalence
    • 9.4.9.3. Competitive Scenario
    • 9.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5.2. China
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Target Disease Prevalence
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. China Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5.3. Japan
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Target Disease Prevalence
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Target Disease Prevalence
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. India Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Target Disease Prevalence
    • 9.5.5.3. Competitive Scenario
    • 9.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Target Disease Prevalence
    • 9.5.6.3. Competitive Scenario
    • 9.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Target Disease Prevalence
    • 9.5.7.3. Competitive Scenario
    • 9.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Latin America Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Target Disease Prevalence
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Target Disease Prevalence
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Argentina Market estimates and forecast, 2018 - 2030 (USD Billion)
• 9.7. MEA
  • 9.7.1. MEA Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Target Disease Prevalence
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7.3. South Africa
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Target Disease Prevalence
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Target Disease Prevalence
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Target Disease Prevalence
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Company Categorization
• 10.2. Strategy Mapping
• 10.3. Company Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. Thermo Fisher Scientific, Inc.
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Merck KGaA
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Lonza
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. CN Bio Innovations
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. 3D Biotek LLC
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Kuraray Co., Ltd.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Tecan Group Ltd.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Corning Incorporated
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Greiner Bio-One
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. InSphero
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives